Addressing these challenges requires a multidisciplinary approach involving collaboration between engineers, biologists, chemists, and medical professionals. Key strategies include:
Conducting extensive preclinical testing to assess the safety and efficacy of nanomaterials. Developing standardized protocols for nanocharacterization to ensure consistent quality and performance of nanomaterials. Engaging with regulatory bodies early in the development process to navigate regulatory hurdles efficiently. Fostering public awareness and dialogue to address ethical and social implications of nanotechnology in medicine.
